US Patent 10316089 PD-1 antibodies
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+218 characters)
Article
Patent abstract
The present invention relates to antibodies that bind human programmed cell death 1 (PD-1), and may be useful for treating cancer alone and in combination with chemotherapy and other cancer therapeutics.
Edits on 1 Nov, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Andy Tsun0
Cheng Chen0
Dechao Michael Yu0
Hemanta Baruah0
Xiaolin Liu0
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
103160890
Date of Patent
June 11, 2019
0Patent Application Number
152320260
Date Filed
August 9, 2016
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 26 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 10316089 PD-1 antibodies
Infobox
Is a
Patent jurisdiction
Patent number
10316089
Date of patent
June 11, 2019
Patent application number
15232026
Date Filed
August 9, 2016
Patent primary examiner
Find more entities like US Patent 10316089 PD-1 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
